Interferon induction of TAP1: The phosphatase SHP-1 regulates crossover between the IFN-α/β and the IFN-γ signal-transduction pathways

Circulation Research

Volumn 83, Issue 8, 1998, Pages 815-823

  Min, Wang ^a   Pober, Jordan S ^a   Johnson, David R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cell; Interferon; MHC class I; Phosphatase; Transporter associated with antigen processing (TAP)

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOSPHATASE; PROTEIN TYROSINE KINASE;

ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REPORTER GENE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0032547850     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.8.815     Document Type: Article

References (46)

1. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature. 1992;355:644-646.
2. Van Kaer L, Ashton-Rickardt P, Ploegh H, Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4-CD8+T cells. Cell. 1992;71:1205-1214.
3. de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis S, Donate L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falkenrodt A, Cazenave J-P, Trowsdale J, Tongio M-M. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science. 1994;265:237-241.
4. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science. 1990;247:715-718.
5. Joly E, Mucke L, Oldstone M. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991;253: 1283-1285.
6. Messadi D, Pober J, Murphy G. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture. Lab Invest. 1988;58:61-67.
7. Friedman R, Stark G. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature. 1985;314:637-639.
8. Johnson D, Pober J. Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc Natl Acad Sci U S A. 1990;87: 5183-5187.
9. Darnell J Jr. STATs and gene regulation. Science. 1997;277:1630-1635.
10. Firmbach-Kraft I, Byers M, Shows T, Dalla F, Krolewski J. Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene. 1990;5:1329-1336.
11. David M, Larner A. Activation of transcription factors by interferon-alpha in a cell-free system. Science. 1992;257:813-815.
12. Fu X-Y, Kessler D, Veals S, Levy D, Darnell JE Jr. ISGF3, the transcriptional activator induced by interferon α, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A. 1990;87: 8555-8559.
13. Levy D, Kessler D, Pine R, Reich N, Darnell J Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative control. Genes Dev. 1988;2:383-393.
14. Harpur A, Andres A, Ziemiecki A, Aston R, Wilks A. JAK2, a third member of the JAK family of protein tyrosine kjnases. Oncogene. 1992; 7:1347-1353.
15. Decker T, Lew DJ, Mirkovitch J, Darnell JE Jr. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J. 1991;10: 927-932.
16. Levy D, Lew D, Decker T, Kessler D, Darnell J Jr. Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 1990;9:1105-1111.
17. Decker T, Lew D, Darnell J Jr. Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol Cell Biol. 1991;11: 5147-5153.
18. Shuai K, Schindler C, Prezioso V, Darnell J Jr. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science. 1992;258:1808-1812.
19. Scharenberg A, Kinet J-P. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell. 1996;87:961-964.
20. David M, Zhou G, Pine R, Dixon J, Larner A. The SH2 domain-containing tyrosine phosphate PTP1D is required for interferon α/β-induced gene expression. J Biol Chem. 1996;271:15862-15865.
21. Adachi M, Fischer E, Ihle J, Imai K, Jirik F, Neel B, Pawson T, Shen S-H, Thomas M, Ullrich A, Zhao Z. Mammalian SH2-containing protein tyrosine phosphatases [letter]. Cell. 1996;85:15.
22. David M, Chen H, Goelz S, Lamer A, Neel B. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol. 1995;15: 7050-7058.
23. Yetter A, Uddin S, Krolewski J, Jiao H, Yi T, Platanias L. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem. 1995;270:18179-18182.
24. Massa P, Wu C. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells. J Immunol. 1996;157: 5139-5144.
25. Beauchemin N, Kunath T, Robitaille J, Chow B, Turbide C, Daniels E, Veillette A. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene. 1997; 14:783-790.
26. You M, Zhao Z. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-γ-stimulated activation of STAT transcription factors in HeLa cells. J Biol Chem. 1997;272:23376-23381.
27. Epperson D, Arnold D, Spies T, Cresswell P, Pober J, Johnson D. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol. 1992;149:3297-3301.
28. Ma W-L, Lehner P, Cresswell P, Pober J, Johnson D. Interferon-γ rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells. J Biol Chem. 1997;272: 16585-16590.
29. Min W, Pober J, Johnson D. Kinetically-coordinated induction of TAP1 and HLA class I by IFN-γ: the rapid induction of TAP1 by IFN-γ is mediated by STAT1α. J Immunol. 1996;156:3174-3183.
30. Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. Eur Mol Biol Org J. 1994;13:158-167.
31. Johnson D, Pober J. HLA class I heavy chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol. 1994;14:1322-1332.
32. Benjamin R, Madrigal J, Parham P. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature. 1991;351:74-77.
33. Pober J, Orosz C, Rose M, Savage C. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation. 1996;61: 343-349.
34. Ledebur H, Parks T. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokine in human endothelial cells. J Biol Chem. 1995;270:933-943.
35. Schreiber E, Matthias P, Müller M, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.
36. Dignam J, Martin P, Shastry B, Roeder R. Eukaryotic gene transcription with purified components. Methods Enzymol. 1983;101: 582-598.
37. White L, Wright K, Felix N, Ruffner H, Reis L, Pine R, Ting J. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1 -/- mice. Immunity. 1996;5:365-376.
38. John J, McKendry R, Pellegrini S, Flavell D, Kerr I, Stark G. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol Cell Biol. 1991;11:4189-4195.
39. Improta T, Schindler C, Horvath C, Kerr I, Stark G, Darnell J Jr. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc Natl Acad Sci U S A. 1994;91:4776-4780.
40. Bluyssen H, Muzaffar R, Vlieststra R, van der Made A, Leung S, Stark G, Kerr I, Trapman J, Levy D. Combinatorial association and abundance of the components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A. 1995;92:5645-5649.
41. Darnell J Jr, Kerr I, Stark G. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science. 1994;264:1415-1421.
42. Penninger J, Sirard C, Mittrücker H-W, Chidgey A, Kozieradzki I, Ngheim M, Hakem A, Kimura T, Timms E, Boyd R, Taniguchi T, Matsuyama T, Mak T. The interferon regulatory transcription factor IRF-1 controls the positive and negative selection of CD8+ thymocytes. Immunity. 1997;7:243-254.
43. Ghislain J, Fish E. Application of genomic DNA affinity chromatography identifies multiple interferon-a-regulated Stat2 complexes. J Biol Chem. 1996;21:12408-12413.
44. Li X, Leung S, Qureshi S, Darnell J Jr, Stark G. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J Biol Chem. 1996;271:5790-5794.
45. David M, Grimley P, Finbloom D, Lamer A. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol Cell Biol. 1993;13:7515-7521.
46. Kozlowski M, Mlinaric R, Feng G, Shen R, Pawson T, Siminovitch K. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med. 1993;178:2157-2163.